Drug boost for muscular dystrophy
Early treatment with a drug can delay the onset and progression of heart failure in children with Duchenne muscular dystrophy, research suggests
bdnews24.com News Service
bdnews24.com
Published :
18 Mar 2005, 06:00 PM
Updated :
17 Aug 2022, 08:21 PM
Mach 19 (BDNEWS)-Early treatment with a drug can delay the onset and progression of heart failure in children with Duchenne muscular dystrophy, research suggests, according to wire services.
DMD is an incurable genetic disease causing muscle wastage, which often leads to fatal cardiac problems.
The study shows the drug, perindopril, can slow heart muscle degeneration - and thus ward off heart failure.
The research by Paris's Cochin Hospital involved 57 children, says the Journal of the American College of Cardiology.
Lead researcher Professor Denis Duboc said: "For the first time, we have shown that it is possible to slow progression in this rare degenerative disease.
"In DMD, the heart muscles are affected and cardiac problems are fatal in around 40% of children."
The five-year study focused on the effect on perindopril, a drug from a class known as ACE inhibitors, widely used to treat high blood pressure and heart failure.
Some 57 children with DMD received either perindopril, or a dummy drug.
Professor Duboc said the results suggested early treatment with perindopril might also benefit other people genetically predisposed to heart failure.
It strikes children at a young age, and affects almost exclusively boys who rarely survive beyond their early 30s.
BDNEWS/1230hrs.